Upstream bioprocessing is a fast-paced environment where thousands of samples are screened annually. The demand for sample analysis throughput and rapid method development is high. To meet throughput requirements and achieve a fast time to answer, well-established analytical technologies, such as conventional CE-SDS, SDS-PAGE, and LC/MS, may face challenges due to their traditionally low throughput and labor-intensive nature.
Discover solutions to address the analytical challenges in early drug development with streamlined workflows for protein purity analysis and fast glycan profiling.
CE-SDS is the industry standard assay for assessing protein purity, integrity, and stability of biotherapeutics. Discover solutions to optimize this assay with validated kits and methods with the below content:
Glycan analysis provides key information on critical quality attributes that could affect stability, safety and efficacy of a protein therapeutic. Discover rapid solutions for N-glycan analysis in the content below: